Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
5.7800
+0.2000 (3.58%)
NASDAQ · Last Trade: Jul 23rd, 1:36 AM EDT
Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovation
By Liminatus Pharma Inc. · Via GlobeNewswire · July 22, 2025

Power Metallic Mines Inc. (TSX.V: PNPN) (OTCQB: PNPNF) has announced high-grade results from its Winter 2025 drill program, including a standout intercept of 12.54 meters at 10.99% CuEq from hole PML-25-012a at the Lion Zone . The interval includes 3.10 g/t gold, 25.52 g/t silver, 4.09% copper, 12.06 g/t palladium, and 2.00 g/t platinum.
Via AB Newswire · June 5, 2025